Ligand validation:6FCI

PRP: 1-O-pyrophosphono-5-O-phosphono-alpha-D-ribofuranose

PRP is a Ligand Of Interest in 6FCI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6FCI_PRP_D_201	96%	57%	0.07	0.978	0.67	0.96	-	-	0	0	100%	1
6FCI_PRP_B_201	91%	58%	0.086	0.974	0.61	0.98	-	1	1	0	100%	1
6FCI_PRP_C_201	86%	59%	0.096	0.966	0.62	0.96	-	-	1	0	100%	1
6FCI_PRP_A_201	86%	58%	0.097	0.964	0.64	0.97	-	-	0	0	100%	1
6FCH_PRP_B_201	98%	60%	0.068	0.988	0.68	0.83	-	-	0	0	100%	1
1ZN7_PRP_A_502	95%	56%	0.076	0.979	0.62	1.05	-	1	1	0	100%	0.5
6FD4_PRP_B_201	95%	62%	0.078	0.981	0.67	0.78	-	-	0	0	100%	1
6HGQ_PRP_D_201	92%	52%	0.081	0.971	0.69	1.14	-	1	1	0	100%	1
6FD5_PRP_B_200	77%	60%	0.12	0.959	0.55	0.98	-	1	0	0	100%	0.7
1FSG_PRP_C_303	100%	43%	0.03	0.996	1.04	1.16	1	1	0	0	100%	1
6D9R_PRP_A_202	98%	4%	0.062	0.988	4.35	1.47	7	7	0	0	100%	1
1TC2_PRP_B_811	98%	29%	0.064	0.985	1.28	1.53	2	4	0	0	100%	1
3DKL_PRP_B_504	98%	47%	0.068	0.987	0.71	1.32	-	6	1	0	100%	1
1I0L_PRP_B_811	97%	28%	0.066	0.982	1.43	1.48	3	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.